| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new era in hypertension research: discussing the findings of ALLHAT
|
Furberg, Curt D
|
|
2001
|
2 |
6 |
p. 249-250
|
artikel
|
| 2 |
Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
|
Gavras, Irene
|
|
2001
|
2 |
6 |
p. 257-259
|
artikel
|
| 3 |
Biventricular pacing in heart failure: update on results from clinical trials
|
Haywood, Guy
|
|
2001
|
2 |
6 |
p. 292-297
|
artikel
|
| 4 |
Comments on ALLHAT and doxazosin
|
Krakoff, Lawrence R
|
|
2001
|
2 |
6 |
p. 254-256
|
artikel
|
| 5 |
Cytokines as new treatment targets in chronic heart failure
|
Damås, Jan Kristian
|
|
2001
|
2 |
6 |
p. 271-277
|
artikel
|
| 6 |
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
|
Bhatt, Deepak L
|
|
2001
|
2 |
6 |
p. 260-262
|
artikel
|
| 7 |
Debate: PCI vs CABG: a moving target, but we are gaining
|
Holmes, David R
|
|
2001
|
2 |
6 |
p. 263-265
|
artikel
|
| 8 |
Debate: Should statin be used in patients with heart failure?
|
Pietro Maggioni, Aldo
|
|
2001
|
2 |
6 |
p. 266-267
|
artikel
|
| 9 |
Debate: Statins should be used in patients with heart failure
|
Kjekshus, John
|
|
2001
|
2 |
6 |
p. 268-270
|
artikel
|
| 10 |
Distal protection devices during percutaneous coronary and carotid interventions
|
Fasseas, Panayotis
|
|
2001
|
2 |
6 |
p. 286-291
|
artikel
|
| 11 |
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
|
Thijs, Lutgarde
|
|
2001
|
2 |
6 |
p. 298-306
|
artikel
|
| 12 |
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
|
Hooper, Philip L
|
|
2001
|
2 |
6 |
p. 251-253
|
artikel
|
| 13 |
Therapeutic angiogenesis for cardiovascular disease
|
Ng, Yin-Shan
|
|
2001
|
2 |
6 |
p. 278-285
|
artikel
|
Tijdschrift beschrijving